5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.47▼ | 2.47▼ | 2.50▼ | 2.43▼ | 2.90▼ |
MA10 | 2.56▼ | 2.55▼ | 2.56▼ | 2.53▼ | N/A |
MA20 | 2.59▼ | 2.60▼ | 2.56▼ | 2.85▼ | N/A |
MA50 | 2.49▼ | 2.88▼ | 3.17▼ | N/A | N/A |
MA100 | 3.26▼ | N/A | N/A | N/A | N/A |
MA200 | N/A | N/A | N/A | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.029▼ | 0.000▲ | 0.025▲ | 0.001▲ | N/A |
RSI | 40.947▼ | 41.270▼ | 40.997▼ | 36.678▼ | N/A |
STOCH | 16.987▼ | 16.987▼ | 25.962 | 45.706 | N/A |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -60.355 | N/A |
CCI | -141.489▼ | -144.321▼ | -172.650▼ | -88.964 | N/A |
Friday, November 22, 2024 10:36 AM
Dogwood previously supplied the BHC Dogwood Therapeutics Inc (DWTX) reports significant advancements in clinical trials and secures strategic financing to bolster its pipeline and future development. ...
|
Monday, November 18, 2024 05:50 AM
Dogwood (DWTX) Therapeutics “announced top line data from the recently completed BHC IMC-2 Long-COVID study. The study was conducted via an investigator-initiated, investigational research grant ...
|
Wednesday, November 13, 2024 04:00 PM
Dogwood Therapeutics, Inc. (NASDAQ:DWTX – Free Report) – Stock analysts at Zacks Small Cap reduced their FY2024 EPS estimates for Dogwood Therapeutics in a research report issued on Monday ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
05/12/24 | 2.40 | 2.54 | 2.29 | 2.29 | 54,100 |
04/12/24 | 2.57 | 2.57 | 2.39 | 2.52 | 9,800 |
03/12/24 | 2.48 | 2.66 | 2.45 | 2.515 | 23,700 |
02/12/24 | 2.36 | 2.701 | 2.36 | 2.43 | 23,800 |
29/11/24 | 2.5647 | 2.5647 | 2.40 | 2.40 | 19,459 |
27/11/24 | 2.73 | 2.87 | 2.58 | 2.60 | 43,500 |
26/11/24 | 2.679 | 2.82 | 2.55 | 2.645 | 11,100 |
25/11/24 | 2.54 | 2.71 | 2.46 | 2.68 | 25,333 |
22/11/24 | 2.60 | 2.74 | 2.46 | 2.55 | 103,054 |
21/11/24 | 2.36 | 2.85 | 2.09 | 2.71 | 135,400 |
|
|
||||
|
|
||||
|
|